PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $31,350,000 | -25.3% | 8,250,000 | 0.0% | 0.27% | -4.9% |
| Q4 2019 | $41,993,000 | +13.0% | 8,250,000 | +12.2% | 0.28% | +0.7% |
| Q3 2019 | $37,154,000 | +8.6% | 7,350,000 | +32.6% | 0.28% | +26.6% |
| Q2 2019 | $34,203,000 | +75.5% | 5,543,386 | +32.0% | 0.22% | +51.0% |
| Q1 2019 | $19,492,000 | +10.5% | 4,200,820 | 0.0% | 0.15% | +14.0% |
| Q4 2018 | $17,643,000 | -22.1% | 4,200,820 | +16.3% | 0.13% | -3.7% |
| Q3 2018 | $22,652,000 | +6.3% | 3,612,820 | +36.3% | 0.13% | +1.5% |
| Q2 2018 | $21,315,000 | – | 2,651,100 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 17,902,338 | $135,342,000 | 5.88% |
| TIGER MANAGEMENT L.L.C. | 1,288,454 | $9,741,000 | 1.91% |
| Phocas Financial Corp. | 1,047,181 | $7,917,000 | 0.69% |
| TUDOR INVESTMENT CORP ET AL | 2,370,503 | $17,921,000 | 0.62% |
| EAM Investors, LLC | 553,309 | $4,183,000 | 0.58% |
| Baker Brothers Advisors | 4,449,797 | $33,640,000 | 0.34% |
| TFS CAPITAL LLC | 463,740 | $3,506,000 | 0.33% |
| FEDERATED HERMES, INC. | 13,508,290 | $102,123,000 | 0.32% |
| Rotella Capital Management, Inc. | 36,473 | $276,000 | 0.24% |
| OXFORD ASSET MANAGEMENT LLP | 1,103,848 | $8,351,000 | 0.18% |